Skip to content

Clinical trials

Phase 4 Lung Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Phase: Phase 4 Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20051
20061
20071
20083
20091
20105
20113
20121
20131
20141
20155
20161
20195
20203
20211
20221
20233
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Unknown status6
Terminated5
Recruiting3
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Novartis Pharmaceuticals3
ActiViews Ltd.2
Assistance Publique - Hôpitaux de Paris1
Bayer1
BioNTech SE1
Bispebjerg Hospital1
Bracco Diagnostics, Inc1
British Thoracic Society1
Children's Hospital Medical Center, Cincinnati1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases43
Pulmonary Disease, Chronic Obstructive12
Respiratory Tract Diseases9
Asthma5
Lung Diseases, Obstructive4
Bronchitis, Chronic3
Dyspnea3
Lung Neoplasms3
Pneumonia3
Pulmonary Eosinophilia3

Trials

Showing 76 to 43 of 43. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.